Kiniksa Pharmaceuticals International (KNSA) Net Margin (2021 - 2026)
Kiniksa Pharmaceuticals International's Net Margin was 10.44% in Q2 2026, down 0.93 percentage points from 11.37% a year earlier and down 0.10 percentage points from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Net Margin (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Kiniksa Pharmaceuticals International's Net Margin was 9.59% through Jun 30, 2026, up 8.69 percentage points year-over-year; for FY2025, it was 8.71%, up 18.91 percentage points from FY2024.
- Net Margin shows a four-year change of +418.43 percentage points (FY2021 to FY2025).
- In earlier years, Net Margin was -10.21% in FY2024 (-15.42 pp), 5.21% in FY2023 (-78.07 pp), 83.28% in FY2022 (+493.00 pp) and -409.72% in FY2021.
- Quarterly Net Margin has moved between -252.53% (Q3 2021) and 226.05% (Q3 2022) over five years.
- Compared with a year earlier, Net Margin was higher in six of the last eight quarters, with an average year-over-year change of +6.80 percentage points.
- The best year-over-year quarter for Net Margin over five years was Q3 2022 (a gain of 478.58 percentage points); the worst was Q3 2023 (a drop of 246.71 percentage points).
- Per Business Quant data, KNSA's Net Margin in the three quarters before Q2 2026 was 10.54% (Q1 2026), 7.02% (Q4 2025) and 10.19% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Kiniksa Pharmaceuticals International | 11.87 Bn | 10.61 Bn | 220.03 Mn | 10.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.44% |
| Mar 31, 2026 | 10.54% |
| Dec 31, 2025 | 7.02% |
| Sep 30, 2025 | 10.19% |
| Jun 30, 2025 | 11.37% |
| Mar 31, 2025 | 6.20% |
| Dec 31, 2024 | -7.25% |
| Sep 30, 2024 | -11.31% |
| Jun 30, 2024 | -3.60% |
| Mar 31, 2024 | -22.17% |
| Dec 31, 2023 | 30.26% |
| Sep 30, 2023 | -20.66% |
| Jun 30, 2023 | 20.95% |
| Mar 31, 2023 | -25.38% |
| Dec 31, 2022 | 7.21% |
| Sep 30, 2022 | 226.05% |
| Jun 30, 2022 | -74.08% |
| Mar 31, 2022 | -78.32% |
| Dec 31, 2021 | -193.83% |
| Sep 30, 2021 | -252.53% |
API Access
Kiniksa Pharmaceuticals International Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();